How large is the quinine sulfate market, and what is its growth trajectory?
The quinine sulfate market size has grown strongly in recent years. It will grow from $2.41 billion in 2024 to $2.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing malaria prevalence, demand for anti-malarial treatments, rising pharmaceutical manufacturing, growing awareness of quinine’s therapeutic uses, and rising demand in tropical regions.
The quinine sulfate market size is expected to see strong growth in the next few years. It will grow to $3.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing focus on tropical disease treatment, rising healthcare expenditure in developing nations, demand for muscle relaxant medications, growing population in malaria-endemic areas, and improving the supply chain for raw materials. Major trends in the forecast period include increasing demand for generic anti-malarial drugs, rising investment in healthcare in emerging markets, technological integration in pharmaceutical production, growing regulatory emphasis on drug safety, and increased global focus on malaria eradication strategies.
Get Your Free Sample of The Global Quinine Sulfate Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19165&type=smp
What are the key forces behind the quinine sulfate market’s growth in recent years?
Growing malaria incidence is expected to propel the growth of the quinine sulfate market going forward. Malaria is a life-threatening infectious disease caused by Plasmodium parasites, transmitted to humans through the bites of infected female Anopheles mosquitoes, leading to symptoms such as fever, chills, and flu-related illness. The rise in malaria cases is attributed to factors such as the development of drug-resistant strains, expanding mosquito habitats due to climate change, and insufficient healthcare. Quinine sulfate is used to treat malaria by killing the Plasmodium parasites responsible for the infection. It works by disrupting the parasite’s ability to grow and reproduce within red blood cells. For instance, in October 2023, according to the World Malaria Report 2023 published by the World Health Organization (WHO), a Switzerland-based United Nations agency, an estimated 249 million malaria cases were reported globally in 2022 across 85 endemic countries, reflecting a 5 million increase from 2021. Therefore, growing malaria incidence is driving the quinine sulfate market.
What are the major segments of the quinine sulfate market?
The quinine sulfatemarket covered in this report is segmented –
1) By Type: 200mg, 300mg, Other Types
2) By Product: Quinine Sulfate Tablets, Quinine Sulfate Capsules, Quinine Sulfate Injections, Quinine Sulfate Powder, Quinine Sulfate Oral Solutions
3) By Distribution Channel: Hospitals, Retail Pharmacies, Online Pharmacies
4) By Application: Malaria, Problematic Leg Cramps, Lupus, Rheumatoid Arthritis, Other Applications
5) By End-User: Adults, Pediatrics, Geriatrics
Subsegments:
1) By 200 mg: Tablets, Oral Solutions, Capsules
2) By 300 mg: Tablets, Oral Solutions, Capsules
3) Other Types: Injectable Forms, Extended Release Formulations, Combination Products
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/quinine-sulfate-global-market-report
Which companies dominate the quinine sulfate market?
Major companies operating in the quinine sulfate market are Sanofi SA, Thermo Fisher Scientific Inc., Viatris Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla Limited, Lupin Limited, Strides Pharma, Taj Pharmaceuticals, Wockhardt Ltd., Alchem International Private Limited, SimSon Pharma Limited, Hangzhou Dayang Co. Ltd., Haihang Industry Co. Ltd., Pharmakina SA, Aecochem Corp, Buchler GmbH, Prism Industries Private Limited, Shreeji Pharma International, Trademax Pharmaceuticals & Chemicals, Sihauli Chemicals Private Limited
What major trends will shape the quinine sulfate market during the forecast period?
Major companies operating in the quinine sulfate market are focusing on developing innovative solutions, such as efficient synthesis of quinine and its derivatives, to streamline the production process of quinine and its derivatives, reducing time, waste, and cost while enhancing chemical synthesis capabilities. The synthesis method for quinine sulfate involves chemical processes to create the compound in a lab, mimicking its natural extraction from the bark of the cinchona tree. This method allows for large-scale production of the drug for treating malaria. For instance, in December 2022, Tohoku University, a Japan-based research university, achieved efficient enantioselective synthesis of quinine. This research features an efficient one-pot synthesis of quinine and its derivatives, utilizing organocatalysts to streamline the process and reduce the number of steps required. This advancement is significant as it minimizes chemical waste, cuts production time, and potentially lowers costs, thereby facilitating the development of new medications and improving the overall synthesis efficiency.
What are the key regional dynamics of the quinine sulfate market, and which region leads in market share?
Asia-Pacific was the largest region in the quinine sulfate market in 2024. The regions covered in the quinine sulfate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Quinine Sulfate Market Report 2025 Offer?
The quinine sulfate market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Quinine sulfate is a naturally derived alkaloid medication extracted from the bark of the cinchona tree, commonly employed in pharmaceutical formulations for its therapeutic properties. It is primarily used to treat malaria and alleviate nocturnal leg cramps, due to its ability to interfere with the reproduction of malaria-causing parasites and relax muscle contractions.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19165
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
